Av-Phos 250 Neutral By AvKARE Overview & Drug Interactions

Check For Interactions With Av-Phos 250 Neutral

Supplement: Av-Phos 250 Neutral by AvKARE

Av-Phos 250 Neutral Label Images

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with Av-Phos 250 Neutral by AvKARE

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Adults and children 4 or more years of age
Minimum serving Sizes:
1 Tablet(s)
Maximum serving Sizes:
1 Tablet(s)
Servings per container 100
UPC/BARCODE 342291152014

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
Dibasic Sodium Phosphate Anhydrous
852 mg
TBD --
Monobasic Potassium Phosphate
155 mg
Potassium --
Monobasic Sodium Phosphate Monohydrate
130 mg
Sodium Phosphate --
Phosphorus
250 mg
Phosphorus 25%
Sodium
298 mg
Sodium
Potassium
45 mg
Potassium

Other Ingredients:


Label Statments:


General Statements
- NDC 42291-152-01 Peel here
Formula
- Prescription phosphorous Supplying 250 mg per tablet
FDA Statement of Identity
- Dietary Supplement
Suggested/Recommended/Usage/Directions
- Must be used under the supervision of a physician.

Brand Information

Manufacturer
Name AvKare

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.